Nutrition Ingredient Companies Secured New Funding

Three businesses earned investment and partnerships to advance the development of new health-focused ingredients.

Updated on Sept. 29, 2026 in Healthy Food

Bold vector editorial illustration of a laboratory flask containing fine powder on a metal bench, representing nutritional supplement innovation. — Three nutritional ingredient companies secured new capital and partnerships this week, aiming to scale health-focused compound production for the wellness market. AI Illustration. Upload story photo >

Live Poll

Do you believe new scientific breakthroughs in food ingredients lead to better health outcomes for you?

Three ingredient companies have recently closed investment rounds or secured partnerships following presentations at Nutrition Capital Network meetings. These developments represent a shift in the pipeline for ingredients intended for the health and wellness market.

Why it matters

Securing capital and industry partnerships is a critical step for ingredient manufacturers to scale their technologies and bring new health-focused products to market. These collaborations often determine which innovations in standardized extracts and nutritional compounds eventually reach the consumer.

Multiple ingredient companies successfully finalized funding or partnership agreements following their presentations at recent Nutrition Capital Network meetings. Whether these specific investments translate into wider market availability for their products remains to be determined.

The players

Nutriventia

An ingredient company that recently closed a growth investment from NDude Labs.

Oleolive

A manufacturer that utilizes patented technology to standardize olive extract.

Ful Foods

A company that secured funding and partnerships through the 2025 NCN meeting.

Applied Food Sciences

A food and nutrition ingredient partner that finalized an agreement with Oleolive.

Next Gen Nutrition Investment Partners

An investment firm that co-led the funding round for Ful Foods.

The details

Companies participate in these meetings to present business models and evidence for their ingredients, such as patented processing technologies that allow for the standardization of extracts. For instance, manufacturers may use proprietary methods to ensure consistent levels of key active compounds in their products, like the two active components found in Oligen. By partnering with established firms, these innovators gain the infrastructure necessary to move from lab-scale production to broader commercial distribution.

Nutrition Capital Network investor meetings launched in 2009.
Oleolive participated in the SupplySide NCN meeting in 2024.
Nutriventia and Ful Foods presented at NCN meetings in 2025.
The next investor and partner meeting is scheduled for October 27, 2026.

Health Landscape

The Nutrition Capital Network Investor and Partner Meeting serves as a central hub for connecting emerging ingredient startups with commercial funding, mirroring the role similar accelerators play in the broader wellness industry. This event reflects the ongoing trend of ingredient manufacturers utilizing dedicated investor forums to scale their commercial operations.

While these investments help bring new ingredients to market, they do not change current medical advice or dietary recommendations. Consumers should always prioritize whole foods and consult a physician before incorporating new supplements or ingredient-heavy products into their routine.

The takeaway

The funding of new ingredient manufacturers suggests that consumers will see more standardized extracts on store shelves in the coming years. When evaluating new health products, focus on transparency regarding the ingredients used rather than the brand's funding status.